RICHMOND, Va.--(

弗吉尼亚州里士满--(

BUSINESS WIRE

商业热线

)--The U.S. Food and Drug Administration (FDA) today authorized

)--美国食品和药物管理局（FDA）今天授权

ZYN

ZYN

nicotine pouches making

尼古丁袋制作

ZYN

ZYN

the first and only authorized nicotine pouch in the United States. The FDA’s authorization of all

美国第一个也是唯一一个获得授权的尼古丁袋。FDA授权所有

ZYN

ZYN

nicotine pouches currently marketed by Swedish Match in the U.S. is an important step to protect the public health by providing better alternatives to cigarettes and other traditional tobacco products for adults 21+.

瑞典Match目前在美国销售的尼古丁袋是保护公众健康的重要一步，为21岁以上的成年人提供更好的香烟和其他传统烟草产品的替代品。

“An estimated 45 million Americans regularly consume nicotine and about 30 million of them smoke, the most harmful form of nicotine consumption,” said Tom Hayes, president of Swedish Match North America, LLC. “The FDA’s decision recognizes the role that

瑞典Match North America，LLC总裁汤姆·海斯（TomHayes）表示：“据估计，有4500万美国人经常服用尼古丁，其中约3000万人吸烟，这是尼古丁消费中最有害的一种形式。”FDA的决定认识到了

ZYN

ZYN

can play in the protection of the public health by helping people switch from cigarettes and other traditional tobacco products.”

通过帮助人们摆脱香烟和其他传统烟草产品，可以在保护公众健康方面发挥作用。”

The FDA authorized the following products:

FDA批准了以下产品：

ZYN

ZYN

Cool Mint 3 mg

清凉薄荷3毫克

ZYN

ZYN

Cool Mint 6 mg

清凉薄荷6毫克

ZYN

ZYN

Peppermint 3 mg

薄荷3毫克

ZYN

ZYN

Peppermint 6 mg

薄荷6毫克

ZYN

ZYN

Spearmint 3 mg

留兰香3毫克

ZYN

ZYN

Spearmint 6 mg

ZYN

ZYN

Wintergreen 3 mg

冬青3毫克

ZYN

ZYN

Wintergreen 6 mg

冬青6毫克

ZYN

ZYN

Citrus 3 mg

ZYN

ZYN

Citrus 6 mg

柑橘6毫克

ZYN

ZYN

Coffee 3 mg

咖啡3毫克

ZYN

ZYN

Coffee 6 mg

咖啡6毫克

ZYN

ZYN

Cinnamon 3 mg

肉桂3毫克

ZYN

ZYN

Cinnamon 6 mg

肉桂6毫克

ZYN

ZYN

Smooth 3 mg

平滑3毫克

ZYN

ZYN

Smooth 6 mg

光滑6毫克

ZYN

ZYN

Chill 3 mg

冷却3毫克

ZYN

ZYN

Chill 6 mg

冷却6毫克

ZYN

ZYN

Menthol 3 mg

薄荷醇3毫克

ZYN

ZYN

Menthol 6 mg

薄荷醇6毫克

The FDA’s decision can be found

FDA的决定可以找到

here.

在这里。

U.S. Marketing Practices Support 21+ Access Only

U、 美国营销实践仅支持21+访问

Swedish Match N.A. LLC is a subsidiary of Philip Morris International Inc. (PMI). PMI’s U.S. affiliates are committed to responsible marketing practices focused on limiting access to adults 21 years of age and older. PMI’s U.S. affiliates do not use social media influencers in the U.S. or people under the age of 35 in marketing materials.

瑞典Match N.A.LLC是菲利普莫里斯国际公司（PMI）的子公司。PMI的美国分支机构致力于负责任的营销实践，重点是限制21岁及以上的成年人进入。PMI的美国分支机构不在营销材料中使用美国社交媒体影响者或35岁以下的人。

They also employ independent age-verification systems like “Double Verify” to direct digital advertising to those over 21, and owned digital platforms are age-gated at the point of access and restricted to current nicotine users of legal age. Swedish Match North America is a Manufacturer Advisory Council member of the We Card Program, a national nonprofit serving retailers of age-restricted products, and a founding board member and investor in TruAge®, a free retail technology that provides stores with a more accurate way of age verification, including the ability to detect fake IDs to ensure 21+ access only..

他们还采用独立的年龄验证系统，如“双重验证”，将数字广告定向给21岁以上的人，拥有的数字平台在访问点上受到年龄限制，并且仅限于目前达到法定年龄的尼古丁用户。瑞典Match North America是We Card计划的制造商咨询委员会成员，We Card计划是一家为年龄限制产品零售商提供服务的国家非营利组织，也是TruAge®的创始董事会成员和投资者，TruAge®是一种免费零售技术，为商店提供更准确的年龄验证方式，包括能够检测假ID以确保21岁以上的人才能进入。。

Philip Morris International: Delivering a Smoke-Free Future

菲利普莫里斯国际：打造无烟未来

PMI (PMI) (NYSE: PM) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products.

PMI（PMI）（纽约证券交易所代码：PM）是一家领先的国际烟草公司，积极打造无烟未来，并长期发展其投资组合，将烟草和尼古丁行业以外的产品包括在内。该公司目前的产品组合主要包括香烟和无烟产品。

Since 2008, PMI has invested over $12.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies.

自2008年以来，PMI已投资125多亿美元，为那些原本会继续吸烟的成年人开发、科学证实和商业化创新无烟产品，目标是彻底结束香烟销售。这包括建立世界一流的科学评估能力，特别是在临床前系统毒理学，临床和行为研究以及上市后研究领域。

In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ .

2022年，PMI收购了口服尼古丁输送领域的领导者瑞典Match，创造了一个由这些公司领导的全球无烟冠军。

IQOS

IQOS

and

和

ZYN

ZYN

brands. The U.S. Food and Drug Administration has authorized versions of PMI’s

品牌。美国食品和药物管理局已经批准了PMI的版本

IQOS

IQOS

devices and consumables and Swedish Match’s

设备和消耗品以及瑞典火柴

General

概述

snus as Modified Risk Tobacco Products. Renewal applications for these

鼻烟作为改良风险烟草产品。续展申请

IQOS

IQOS

products are pending before the FDA. As of June 30, 2024, PMI's smoke-free products were available for sale in 90 markets, and PMI estimates that 36.5 million adults around the world use PMI's smoke-free products. The smoke-free business accounted for approximately 38% of PMI’s total first-nine months 2024 net revenues.

产品正在等待FDA的批准。截至2024年6月30日，PMI的无烟产品已在90个市场销售，PMI估计全世界有3650万成年人使用PMI的无烟产品。无烟业务约占PMI 2024年前9个月总净收入的38%。

With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., including its subsidiaries.

凭借强大的生命科学基础和丰富的专业知识，PMI于2021年2月宣布其雄心壮志，将扩展到健康和医疗保健领域，旨在通过提供无缝的健康体验来提高生活质量。“PMI”、“我们”、“我们的”和“我们”是指菲利普莫里斯国际公司，包括其子公司。

For more information, please visit .

有关更多信息，请访问。

www.pmi.com

www.pmi.com

and

和

www.pmiscience.com

www.pmiscience.com

.

.